Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001647488-15-000107
Filing Date
2015-09-17
Accepted
2015-09-17 16:54:08
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-K 765709
2 EXHIBIT 31 ex31.htm EX-31 11237
3 EXHIBIT 32 ex32.htm EX-32 3835
4 EXHIBIT 21 ex21.htm EX-21 694
5 EXHIBIT 24 ex24.htm EX-24 7765
12 GRAPHIC image_001.jpg GRAPHIC 6290
  Complete submission text file 0001647488-15-000107.txt   4087774

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE rcha-20150331.xml EX-101.INS 716692
7 XBRL SCHEMA FILE rcha-20150331.xsd EX-101.SCH 56931
8 XBRL CALCULATION FILE rcha-20150331_cal.xml EX-101.CAL 36046
9 XBRL DEFINITION FILE rcha-20150331_def.xml EX-101.DEF 155449
10 XBRL LABEL FILE rcha-20150331_lab.xml EX-101.LAB 267696
11 XBRL PRESENTATION FILE rcha-20150331_pre.xml EX-101.PRE 248387
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

EIN.: 463259117 | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-54767 | Film No.: 151112705
SIC: 2834 Pharmaceutical Preparations